Medicine
Glipizide and Metformin 2.5 mg/250 mg tablet
Glipizide and Metformin 2.5 mg/250 mg tablet is a generic prescription medicine for oral use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Glipizide and Metformin
- Brand
- Sold under the generic name
- Strength
- 2.5 mg/250 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 90 tablets and 9 more
- Manufacturers
- Zydus LifesciencesIndiaAvet PharmaceuticalsIndiaChartwell RXTeva Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 October 2005
- Identifiers
- RxCUI 861731, 861736, 861740DailyMed set ID 03d9ce02-0559-494c-a53d-de9b9a64b606, 94a7f96e-2ed1-432d-bc6a-5840863816e1, 1b18b903-eb52-4d08-b4a5-f984957eb116 +1NDC 0093-7455, 23155-115, 62135-731 +2Application ANDA077270, ANDA078728, ANDA078905
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 bottle | 65841-659-01 | Zydus LifesciencesIndia | 5 May 2016 |
| 1000 tablet, film coated in 1 bottle | 65841-659-10 | Zydus LifesciencesIndia | 5 May 2016 |
| 90 tablet, film coated in 1 bottle | 65841-659-16 | Zydus LifesciencesIndia | 5 May 2016 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 65841-659-77 | Zydus LifesciencesIndia | 5 May 2016 |
| 100 tablet, film coated in 1 bottle | 68382-184-01 | Zydus LifesciencesIndia | 5 May 2016 |
| 1000 tablet, film coated in 1 bottle | 68382-184-10 | Zydus LifesciencesIndia | 5 May 2016 |
| 90 tablet, film coated in 1 bottle | 68382-184-16 | Zydus LifesciencesIndia | 5 May 2016 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 68382-184-77 | Zydus LifesciencesIndia | 5 May 2016 |
| 100 tablet, film coated in 1 bottle | 23155-115-01 | Avet PharmaceuticalsIndia | 29 June 2010 |
| 1000 tablet, film coated in 1 bottle | 23155-115-10 | Avet PharmaceuticalsIndia | 29 June 2010 |
| 60 tablet, film coated in 1 bottle | 62135-731-60 | Chartwell RX | 15 August 2023 |
| 100 tablet, film coated in 1 bottle | 0093-7455-01 | Teva Pharmaceuticals | 28 October 2005 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 21 October 2002 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Glipizide and Metformin
Clinical summary
Glipizide and Metformin is a fixed-dose combination of a biguanide and a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. MedsAcross supplies Glipizide and Metformin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Glipizide and MetforminFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Glipizide and Metformin Hydrochloride prescribing information (Zydus Lifesciences) · U.S. National Library of Medicine, DailyMed
Need Glipizide and Metformin 2.5 mg/250 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.